SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-03-05
👔
Akebia Therapeutics, Inc.
@AKBA_InsiderForm 4 Filing: Butler John P. Buys $87K of $AKBA
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Akebia Therapeutics, Inc.
Ticker: $AKBA
Transaction Value
$87K
Price/Share: $1.25
transaction date
2026-03-04
Shares: 69,270
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Butler John P., holds the title of CEO and President at Akebia Therapeutics, Inc..
On 2026-03-04, the insider transacted 69,270 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $87K.
Executive Summary Summary
Butler John P. (CEO and President) bought $87K of $AKBA
Post-Transaction Position: 3,367,064 shares
SEC Accession No: 0001591467-26-000003 (CIK: 1591467)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.